Lifetime costs of invasive meningococcal disease: A Markov model approach.

CONCLUSIONS: IMD can result in substantial costs to the healthcare system and society. Understanding the costs of care can assist decision-making bodies in evaluating cost-effectiveness of new vaccine programs.
PMID: 31594708 [PubMed - as supplied by publisher]

Source: Vaccine - October 4, 2019 Category: Allergy & Immunology Authors: Wang B, Haji Ali Afzali H, Giles L, Marshall H Tags: Vaccine Source Type: research